Auto-refill vs. manual refill: how GLP-1 subscriptions should treat you

You did the research. You filled out the intake form. You paid for the first shipment. And then, thirty days later, another charge hit your card before you had a chance to decide whether you even wanted to continue. No warning email. No confirmation step. Just a fait accompli and a customer-service number that goes to voicemail. If that has happened to you, you are not alone, and you are not overreacting. The GLP-1 telehealth space has a subscription-trap problem, and it is worth naming directly before we talk about what a fair model actually looks like.

Why auto-refill is the default, and why that is a problem

Auto-refill is not inherently predatory. For a medication you plan to take long-term, automated reordering can be genuinely convenient. The problem is when it is the default you never agreed to, buried in paragraph fourteen of a terms-of-service document, with cancellation routed through a phone call you have to make during business hours. That is not a subscription model. That is a subscription trap. Community threads on GLP-1 forums light up every month with some version of the same story: 'I got charged for three months before I figured out how to cancel,' or 'they made me talk to a retention specialist just to stop the shipments.' These are not edge cases. They are a business model.

The people most likely to get caught are exactly the readers most likely to be on this page: value-conscious, doing careful research, trying medication for the first time, not sure yet if it is working at their current dose. Those are the patients who most need the flexibility to pause, adjust, or stop without a fight.

What transparent GLP-1 refill terms actually look like

Transparent refill terms are not complicated. They require, at minimum: a clear statement of what you will be charged and when before you complete your first purchase, an opt-in rather than opt-out for recurring billing, a self-serve cancellation path you can complete without calling anyone, and a defined policy on refunds or returns for shipments you did not authorize. If a telehealth provider cannot describe all four of those things in plain language on their pricing page, that is your answer.

• Flat, upfront pricing with no hidden fees disclosed after checkout
• Recurring billing that is clearly opt-in, not buried as a default
• Self-serve cancellation available through your account dashboard
• Refund or return policy that is written down and findable before you pay
• No 'retention call' required to stop shipments

Manual refill, by contrast, means each shipment is authorized by you before it ships. You decide when you are ready for the next dose, you place the order, and you are charged at that point. The trade-off is that you have to remember to reorder, which means you could run out of medication if you wait too long. For patients who are still dialing in their dose or who travel frequently, manual refill often makes more sense. For patients on a stable dose who want the simplicity of not thinking about it, a transparent auto-refill with easy cancellation can work. The point is that neither model is automatically better. What matters is that you chose it knowingly.

How to evaluate whether a GLP-1 telehealth provider is legit on billing

The 'is it legit' question comes up constantly in GLP-1 communities, and billing is one of the fastest ways to get an answer. Providers who are confident in their product do not need to trap you into recurring charges to retain you. The ones who do are usually betting that inertia and cancellation friction will keep your card on file longer than your satisfaction would.

Here is a practical checklist you can run before you hand over payment information. Ask yourself: Is the price per shipment stated clearly before checkout, including any provider or consultation fees? Does the site distinguish between a one-time visit fee and the medication cost? Is there a pharmacy name listed, and does that pharmacy hold a state license and a 503A or 503B designation under federal law? Can you find cancellation instructions without contacting support? Are clinical results attributed correctly to the medication's published trials rather than implied to be the provider's own patient data?

• Price per shipment is stated before checkout, with no surprise fees at confirmation
• Pharmacy name and license class (503A or 503B) are disclosed
• The provider is licensed in your state
• Clinical efficacy figures are attributed to published trials, not the provider's own results
• Cancellation does not require a phone call or a retention conversation
• Shipping timeline and cold-packaging method are described

On the clinical side, it is also worth understanding what the evidence actually says, because a lot of telehealth marketing either overstates outcomes or leaves out enough context to mislead. The SURMOUNT-1 trial of tirzepatide (Jastreboff et al., NEJM 2022) found a mean body-weight loss of up to approximately 20.9 percent at the 15 mg dose over 72 weeks. The STEP-1 trial of semaglutide found approximately 14.9 percent mean weight loss at 68 weeks. These are tirzepatide and semaglutide molecule trial data from controlled clinical settings, not StaveMD patient data, and individual results vary considerably. The NIH 'Biggest Loser' research (Fothergill et al., 2016) documented the biological mechanisms behind metabolic adaptation: your body actively resists weight loss by slowing resting metabolism and increasing hunger hormones. GLP-1 receptor agonists work in part by modulating that hormonal environment. That is biology, not willpower. Knowing the real numbers, and knowing they come from trials rather than marketing copy, is how you evaluate whether a provider is being straight with you.

Compounded vs. brand-name: what that means for your subscription

Most telehealth GLP-1 subscriptions are dispensing compounded semaglutide or compounded tirzepatide, not the FDA-approved brand-name products Zepbound or Mounjaro. Compounded tirzepatide is prepared by a US-licensed compounding pharmacy under a valid prescription from a licensed provider. It is not an FDA-approved finished product, and no telehealth provider, including StaveMD, compounds or manufactures the medication. StaveMD connects you with licensed providers who write prescriptions that are filled at licensed compounding pharmacies.

Why does this matter for billing? Because the compounded-medication supply chain is more variable than a retail pharmacy. Shipping involves cold packaging, carrier coordination, and sometimes state-level licensing constraints. A provider who is upfront about all of that, including what happens if a shipment is delayed or arrives damaged, is giving you information you need before you commit to a subscription. A provider who glosses over the logistics is often also the one who glosses over the billing terms.

The food noise going quiet, the first time in years you are not negotiating with yourself at 9pm, the realization that you did not lack willpower and never did: those outcomes are worth pursuing carefully, with a provider who treats you like an adult. That means honest pricing, a pharmacy you can verify, a provider who has actually reviewed your intake, and a subscription structure that lets you leave without a fight if you need to. You have been dismissed enough times. The least a telehealth provider owes you is transparency before you pay.